TWINBEECH CAPITAL LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,103,169
+72.4%
199,921
+91.1%
0.04%
-38.6%
Q4 2021$1,220,000
+291.0%
104,627
+281.5%
0.07%
+37.3%
Q4 2020$312,000
+169.0%
27,424
+112.1%
0.05%
+104.0%
Q3 2020$116,000
-58.4%
12,931
-52.1%
0.02%
-59.0%
Q2 2020$279,000
+18.7%
27,002
+53.2%
0.06%
-10.3%
Q4 2019$235,00017,6210.07%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders